journal article·2024-11

2D Catalytic Niobium Carbide MXenzyme for Ameliorating Noise‐Induced Hearing Loss

Baoying Xu, Qingjun Jiang, Yuqi Huang, Ke Xu, Wei Feng, Dehong Yu, Yu Chen

Advanced Functional Materials· Volume 34· Issue 46
Publisher page

Abstract

Abstract Noise‐induced hearing loss (NIHL), a prevalent sensory disability affecting a majority of the global population, is dominantly induced by mitochondrial dysfunction and oxidative stress, but no effective therapeutic strategy is available. Herein, the potential of a 2D catalytic niobium carbide (Nb2C) MXenzyme is investigated as a nanomedicine for treating NIHL by scavenging reactive oxygen species (ROS). The findings reveal that 2D Nb2C MXenzyme effectively eliminates free radicals, resulting in a substantial reduction of ROS in House Ear Institute‐Organ of Corti 1 (HEI‐OC1) cells treated with hydrogen peroxide (H2O2). Additionally, the 2D Nb2C MXenzyme demonstrates significant protection on hair cells by preventing cytotoxicity and apoptosis induced by H2O2. In vivo experiments further support the efficacy of the 2D Nb2C MXenzyme in restoring hearing impairment caused by extensive noise exposure. Specifically, it restores the raised amplitude of Wave I in auditory brainstem response (ABR) records and promotes the recovery of damaged ribbon synapses in inner hair cells. Notably, the therapeutic effect of the 2D Nb2C MXenzyme is attributed to its ability to suppress cochlear oxidative stress evidenced by immunohistochemical analysis. This research provides a new approach for treating hearing loss‐related ear diseases by utilizing catalytic biomaterials and nanomedicine with enzyme‐mimicking properties.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Conducting polymers and applications · MXene and MAX Phase Materials · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Materdicine Lab School of Life Sciences Shanghai University Shanghai 200444 P. R. China

Department of Otolaryngology‐Head and Neck Surgery Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200100 P. R. China

Shanghai Institute of Materdicine Shanghai 200051 P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shanghai Municipality · Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases · Shanghai Shuguang Program

References (49)

Show source-provided references
1. Tikka C. · Cochrane Database Syst. Rev. · 2017 · 7 · 1465
2. 10.1038/srep2037410.1038/srep20374 ↗
3. 10.1001/jamaneurol.2022.442710.1001/jamaneurol.2022.4427 ↗
4. 10.1016/j.heares.2023.10878310.1016/j.heares.2023.108783 ↗
5. 10.3390/jcm1206234710.3390/jcm12062347 ↗
6. 10.1155/2021/478438510.1155/2021/4784385 ↗
7. 10.1007/s12264-020-00624-110.1007/s12264-020-00624-1 ↗
8. 10.1007/s00405-014-2922-910.1007/s00405-014-2922-9 ↗
9. 10.1016/j.freeradbiomed.2007.02.00810.1016/j.freeradbiomed.2007.02.008 ↗
10. 10.3390/antiox912117710.3390/antiox9121177 ↗
11. 10.3389/fcell.2021.65948610.3389/fcell.2021.659486 ↗
12. 10.1016/S0378-5955(00)00096-410.1016/S0378-5955(00)00096-4 ↗
13. 10.1021/acs.accounts.9b0014010.1021/acs.accounts.9b00140 ↗
14. 10.1039/C8CS00457A10.1039/C8CS00457A ↗
15. 10.1038/s41565-022-01179-010.1038/s41565-022-01179-0 ↗
16. 10.1007/s40820-021-00717-010.1007/s40820-021-00717-0 ↗
17. 10.1016/j.cej.2020.12605410.1016/j.cej.2020.126054 ↗
18. 10.1002/adma.20210834810.1002/adma.202108348 ↗
19. 10.1016/j.ccr.2022.21478410.1016/j.ccr.2022.214784 ↗
20. 10.1016/j.biomaterials.2023.12217810.1016/j.biomaterials.2023.122178 ↗
21. 10.3389/fbioe.2023.120869310.3389/fbioe.2023.1208693 ↗
22. 10.1002/adfm.20230562510.1002/adfm.202305625 ↗
23. 10.1002/EXP.2022016110.1002/EXP.20220161 ↗
24. 10.1021/accountsmr.2c0002510.1021/accountsmr.2c00025 ↗
25. 10.1016/j.biomaterials.2023.12207410.1016/j.biomaterials.2023.122074 ↗
26. 10.1038/s41467-021-22278-x10.1038/s41467-021-22278-x ↗
27. 10.1002/smll.20220303110.1002/smll.202203031 ↗
28. 10.1002/anie.20230353910.1002/anie.202303539 ↗
29. 10.1016/j.bios.2016.12.06810.1016/j.bios.2016.12.068 ↗
30. 10.1016/j.talanta.2021.12289210.1016/j.talanta.2021.122892 ↗
31. 10.3390/biom1307115610.3390/biom13071156 ↗
32. 10.1093/plcell/koad16710.1093/plcell/koad167 ↗
33. 10.1039/C9TB00525K10.1039/C9TB00525K ↗
34. 10.1021/acsnano.8b0932710.1021/acsnano.8b09327 ↗
35. 10.1016/j.bioactmat.2021.06.01610.1016/j.bioactmat.2021.06.016 ↗
36. 10.3390/antiox1108146910.3390/antiox11081469 ↗
37. 10.1016/j.heares.2021.10840810.1016/j.heares.2021.108408 ↗
38. 10.1121/1.492741810.1121/1.4927418 ↗
39. 10.1152/jn.00342.202110.1152/jn.00342.2021 ↗
40. 10.1016/j.neuroscience.2019.11.05110.1016/j.neuroscience.2019.11.051 ↗
41. 10.1016/j.neuroscience.2020.02.03810.1016/j.neuroscience.2020.02.038 ↗
42. 10.1523/JNEUROSCI.2845-09.200910.1523/JNEUROSCI.2845-09.2009 ↗
43. 10.1021/acsnano.8b0402210.1021/acsnano.8b04022 ↗
44. 10.1002/adma.20221011010.1002/adma.202210110 ↗
45. 10.3390/md1111464110.3390/md11114641 ↗
46. 10.1021/acs.jafc.7b0224710.1021/acs.jafc.7b02247 ↗
47. 10.1016/j.nantod.2022.10158910.1016/j.nantod.2022.101589 ↗
48. 10.1039/D1NR07921B10.1039/D1NR07921B ↗
49. 10.3390/pharmaceutics1311185010.3390/pharmaceutics13111850 ↗